Research Article
Complex Inflammation mRNA-Related Response in ALS Is Region Dependent
Table 1
Summary of clinical and pathological data in the present series.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thirty-three cases are analyzed corresponding to 19 controls and 14 amyotrophic lateral sclerosis (ALS) cases. Some ALS cases have concomitant AD-related pathology at stages I-II of Braak (AD I-II), and for this reason some control cases with similar stages of AD-related pathology are included in the study of the anterior lumbar spinal cord. However, only cases without AD-related pathology are selected for study in the frontal cortex area 8 (see text). M: male; F: female; P-M: postmortem delay (hours, minutes); FC: frontal cortex area 8; SC: anterior lumbar spinal cord; RIN: RNA integrity number. |